Cambridge Enterprise Ventures

Activity in this selectionacf-investors-8e7b5ad7

By stage

Seed2

Series A2

Undisclosed1

Climate tech3

Biotech2

United Kingdom4

Switzerland1

5 in this selection

Jun 23

Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases

$47MSeed+

Role not disclosed

Jun 3

Develops AI-driven control software for energy-intensive industries

$26MSeries A

Role not disclosed

Mar 31

Develops next-generation cell assay technology for drug discovery

$3.8MUndisclosed

Role not disclosed

Mar 10

Develops cellulose-based alternative to titanium dioxide for cosmetics, food, and coatings

Role not disclosed

Feb 10

Develops AI-driven energy management software to optimize energy use in real estate portfolios

Role not disclosed